ColdVentures, maker of rapid core body cooling product ColdVest, have announced the closure of its seed funding round valuing the company at $2.5 million post-money. The round was led by strategic investors and early supporters committed to combating death from heat-related illnesses.
Founded in 2023, ColdVentures has developed a patented, FDA Class 1 medical device that delivers rapid core body cooling through an endothermic reaction, providing relief for individuals experiencing heat stress. The technology is designed for use in various settings, including schools, athletic programs, and workplaces exposed to high temperatures.
ColdVest is being deployed in schools, athletic programs, and job sites across the U.S.—from indoor industrial facilities to outdoor construction zones—where the risk of heat illness is high. The company is also currently operating in Japan and Australia, and is actively looking at expanding into other countries, supporting efforts to protect workers, students and athletes.
